Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of Treatment

 

The FDA is warning that remdesivir shouldn’t be used alongside hydroxychloroquine or chloroquine as it may result in lower antiviral activity for remdesivir. The announcement was based on lab studies, but the interaction has not been observed in the clinical setting. On Monday, the FDA pulled the emergency use authorization for hydroxychloroquine and chloroquine for COVID-19.

https://www.fda.gov/safety/medical-product-safety-information/remdesivir-gilead-sciences-fda-warns-newly-discovered-potential-drug-interaction-may-reduce